Small molecule screen employing patient-derived iPSC hepatocytes identifies LRRK2 as a novel therapeutic target for Alpha1 Antitrypsin Deficiency
Deniz Kent(University of Massachusetts Chan Medical School), S. Tamir Rashid(Stanford University)
Cited by 0
Related Papers
Single cell analysis of human foetal liver captures the transcriptional profile of hepatobiliary hybrid progenitors
|Nature Communications|2019|133
Human iPS derived progenitors bioengineered into liver organoids using an inverted colloidal crystal poly (ethylene glycol) scaffold
|Biomaterials|2018|132
CRISPR/Cas9 microinjection in oocytes disables pancreas development in sheep
|Scientific Reports|2017|83
Mosaicism diminishes the value of pre-implantation embryo biopsies for detecting CRISPR/Cas9 induced mutations in sheep
|Transgenic Research|2018|40
Small molecule screen employing patient-derived iPS hepatocytes identifies LRRK2 as a novel therapeutic target for Alpha1 Antitrypsin Deficiency
|bioRxiv (Cold Spring Harbor Laboratory)|2021|0